Featured Speaker: Karthik Venkatakrishnan, PhD (he/him/his) – EMD Serono
Moderator: Matthew Rizk, PhD (he/him/his) – Merck
Pharmacometrics & Pharmacokinetics (PMK)
Oncology (ONC)
Featured Speaker: Karthik Venkatakrishnan, PhD (he/him/his) – EMD Serono
### he/him/his @@@ Matthew Rizk, PhD (he/him/his) – Merck ### 1481695###Moderator###Executive Director, Quantitative Pharmacology and Pharmacometrics###Merck###Moderator: Matthew Rizk, PhD (he/him/his) – Merck
### he/him/hisChair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
Chair: Shuhan Liu (she/her/hers) – University of Michigan
Speaker: Sharon J. Swan, MBA (she/her/hers) – ASCPT
Speaker: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
Speaker: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
Student & Trainee (ST)
Translational Informatics (TI)
Chair: Mohamed Shahin, PhD, MS – Pfizer, Inc.
### @@@ Shuhan Liu (she/her/hers) – University of Michigan ### 2172604###Chair###Graduate student###University of Michigan###Chair: Shuhan Liu (she/her/hers) – University of Michigan
### she/her/hers @@@ Sharon J. Swan, MBA (she/her/hers) – ASCPT ### 1256287###Speaker###CEO Emeritus###ASCPT###Speaker: Sharon J. Swan, MBA (she/her/hers) – ASCPT
### she/her/hers @@@ Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division ### 1770944###Speaker###SVP Client & Regulatory Strategy###Certara UK Ltd, Simcyp Division###Speaker: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
### @@@ Anuradha Ramamoorthy, PhD – Potomac, MD ### 1156653###Speaker######Potomac, MD###Speaker: Anuradha Ramamoorthy, PhD – Potomac, MD
### @@@ Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana ### 1143999###Speaker###Postdoctoral Fellow###University of Montana###Speaker: Shayna R. Killam, MS, PharmD (she/her/hers) – University of Montana
### she/her/hersChair: Amy Cheung, PhD (she/her/hers) – Certara
Chair: Lionel Tan, MBBS, PhD (he/him/his) – ViiV
Speaker: Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare
Speaker: Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs
Speaker: Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI)
Speaker: Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine
Global Health (GH)
Infectious Diseases (INF)
Chair: Amy Cheung, PhD (she/her/hers) – Certara
### she/her/hers @@@ Lionel Tan, MBBS, PhD (he/him/his) – ViiV ### 2121884###Chair###Medicine Development Lead, Paediatric HIV###ViiV###Chair: Lionel Tan, MBBS, PhD (he/him/his) – ViiV
### he/him/his @@@ Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare ### 2219661###Speaker###Senior Director, Pediatric Clinical Development###ViiV Healthcare###Speaker: Cindy H. Brothers, MPH (she/her/hers) – ViiV Healthcare
### she/her/hers @@@ Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs ### 1819335###Speaker###Regional Medical Scientific Director - Virology###Merck Research Labs###Speaker: Jennifer J. Kiser, PharmD, PhD (she/her/hers) – Merck Research Labs
### she/her/hers @@@ Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI) ### 2230149###Speaker###Senior Director, Product development, Quality, Costing, and Regulatory Affairs###Clinton Health Access Initiative (CHAI)###Speaker: Melynda Watkins (she/her/hers) – Clinton Health Access Initiative (CHAI)
### she/her/hers @@@ Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine ### 2235993###Speaker###Professor of Pediatrics and Section Head, Pediatric Infectious Diseases and Epidemiology###University of Colorado School of Medicine###Speaker: Elizabeth J. McFarland, MD (she/her/hers) – University of Colorado School of Medicine
### she/her/hersState of the Art Speaker: Delali Attiogbe Attipoe, MBA (she/her/hers) – DNDi
Moderator: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
Global Health (GH)
Drug Utilization & Outcomes (DUO)
State of the Art Speaker: Delali Attiogbe Attipoe, MBA (she/her/hers) – DNDi
### she/her/hers @@@ Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division ### 1770944###Moderator###SVP Client & Regulatory Strategy###Certara UK Ltd, Simcyp Division###Moderator: Karen Rowland Yeo, PhD – Certara UK Ltd, Simcyp Division
###Partner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
Partner Presenter: Aernout D. van Haarst, PhD (he/him/his) – Celerion
### he/him/hisExpert: Abigail Gorman
Expert: Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration
Expert: Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb
Expert: Abigail Gorman
### @@@ Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration ### 1770959###Expert###Director, Office of Clinical Pharmacology###U.S. Food and Drug Administration###Expert: Issam Zineh, MPH, PharmD – U.S. Food and Drug Administration
### @@@ Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb ### 1201152###Expert###Associate Director###Bristol Myers Squibb###Expert: Antoinette Ajavon-Hartmann, PhD (she/her/hers) – Bristol Myers Squibb
### she/her/hersPartner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
Partner Presenter: Jocelyn Courville, MBA, MS, PhD – ICON
###Award Lecturer: Kathleen M. Giacomini, PhD – University of California, San Francisco
Award Presenter: Mark Dresser, PhD (he/him/his) – Gilead Sciences
Membrane Transporter (MT)
Pharmacogenomics (PGx)
Award Lecturer: Kathleen M. Giacomini, PhD – University of California, San Francisco
### @@@ Mark Dresser, PhD (he/him/his) – Gilead Sciences ### 956032###Award Presenter###Senior Vice President###Gilead Sciences###Award Presenter: Mark Dresser, PhD (he/him/his) – Gilead Sciences
### he/him/hisChair: Brian Cicali, PhD – Univ of Florida Coll of Pharmacy
Speaker: Paul Liang (he/him/his) – Carnegie Mellon University
Speaker: Wesley Anderson, PhD – Critical Path Institute
Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
Drug Utilization & Outcomes (DUO)
Translational Informatics (TI)
Chair: Brian Cicali, PhD – Univ of Florida Coll of Pharmacy
### @@@ Paul Liang (he/him/his) – Carnegie Mellon University ### 2121863###Speaker###PhD student###Carnegie Mellon University###Speaker: Paul Liang (he/him/his) – Carnegie Mellon University
### he/him/his @@@ Wesley Anderson, PhD – Critical Path Institute ### 2121864###Speaker###Quantitative Medicine Scientist###Critical Path Institute###Speaker: Wesley Anderson, PhD – Critical Path Institute
### @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Speaker###Division Director###US Food and Drug Administration###Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
###Chair: Ted Grasela, PharmD, PhD – Azimuth Global Health Consulting
Chair: David Wesche, MD, PhD – Certara
Speaker: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
Speaker: Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration
Speaker: Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority
Speaker: Jackson Mukonzo, PhD, MSc – Makerere University
Global Health (GH)
Regulatory Science (RS)
Chair: Ted Grasela, PharmD, PhD – Azimuth Global Health Consulting
### @@@ David Wesche, MD, PhD – Certara ### 2121871###Chair######Certara###Chair: David Wesche, MD, PhD – Certara
### @@@ Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation ### 949850###Speaker###Director, Integrated Development; Global Health###Bill & Melinda Gates Foundation###Speaker: Dan Hartman, MD (he/him/his) – Bill & Melinda Gates Foundation
### he/him/his @@@ Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration ### 1143504###Speaker###Director, Division of Cardiometabolic and Endocrine Pharmacology###US Food and Drug Administration###Speaker: Shirley Seo, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority ### 2121873###Speaker###Director Product Safety###National Drug Authority###Speaker: Helen Byomire Ndagije, PhD (she/her/hers) – National Drug Authority
### she/her/hers @@@ Jackson Mukonzo, PhD, MSc – Makerere University ### 2121872###Speaker###Associate Professor & Chair Pharmacology & Therarpeutics Department###Makerere University###Speaker: Jackson Mukonzo, PhD, MSc – Makerere University
###Chair: Lei Zhang, PhD – US Food and Drug Administration
Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
Speaker: Janice Schwartz, MD – University of California, San Francisco
Speaker: James Kirkland, MD, PhD (he/him/his) – Mayo Clinic
Speaker: John Wagner, MD, PhD (he/him/his) – Koneksa Health
Speaker: Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs
Regulatory Science (RS)
Special Populations (SPO)
Chair: Lei Zhang, PhD – US Food and Drug Administration
### @@@ John Wagner, MD, PhD (he/him/his) – Koneksa Health ### 1201986###Chair###Chief Medical Officer###Koneksa Health###Chair: John Wagner, MD, PhD (he/him/his) – Koneksa Health
### he/him/his @@@ Janice Schwartz, MD – University of California, San Francisco ### 1429078###Speaker###Professor###University of California, San Francisco###Speaker: Janice Schwartz, MD – University of California, San Francisco
### @@@ James Kirkland, MD, PhD (he/him/his) – Mayo Clinic ### 2121853###Speaker######Mayo Clinic###Speaker: James Kirkland, MD, PhD (he/him/his) – Mayo Clinic
### he/him/his @@@ John Wagner, MD, PhD (he/him/his) – Koneksa Health ### 1201986###Speaker###Chief Medical Officer###Koneksa Health###Speaker: John Wagner, MD, PhD (he/him/his) – Koneksa Health
### he/him/his @@@ Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs ### 2229070###Speaker###Deputy Director for Clinical Science###FDA/CDER/Office of New Drugs###Speaker: Mary Thanh Hai, MD – FDA/CDER/Office of New Drugs
###Partner Presenter: Piet H. van der Graaf, PharmD, PhD – Certara
Partner Presenter: John Burke – Applied BioMath
Partner Presenter: Fei Hua – Applied BioMath
Partner Presenter: Piet H. van der Graaf, PharmD, PhD – Certara
### @@@ John Burke – Applied BioMath ### 2276009###Partner Presenter###Co-Founder and the President and CEO###Applied BioMath###Partner Presenter: John Burke – Applied BioMath
### @@@ Fei Hua – Applied BioMath ### 2276084###Partner Presenter###VP Modeling and Simulation Services###Applied BioMath###Partner Presenter: Fei Hua – Applied BioMath
###Partner Presenter: Lona Sheeran, BS – Worldwide Clinical Trials
Partner Presenter: Lona Sheeran, BS – Worldwide Clinical Trials
###Award Lecturer: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
Award Presenter: Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill
Early Development & Drug Safety (EDDS)
Membrane Transporter (MT)
Award Lecturer: Kim Brouwer, PharmD, PhD – University of North Carolina at Chapel Hill
### @@@ Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill ### 1819252###Award Presenter###Professor###University of North Carolina at Chapel Hill###Award Presenter: Paul Watkins, MD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisChair: Ravi Shankar P. Singh, PhD (he/him/his) – Pfizer
Chair: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
Speaker: Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb
Speaker: Amita Joshi, PhD (she/her/hers) – Genentech
Speaker: Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool
Early Career (EC)
Student & Trainee (ST)
Chair: Ravi Shankar P. Singh, PhD (he/him/his) – Pfizer
### he/him/his @@@ Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals ### 1143599###Chair###Executive Director, Quantitative Clinical Pharmacology###Takeda Pharmaceuticals###Chair: Neeraj Gupta, PhD (he/him/his) – Takeda Pharmaceuticals
### he/him/his @@@ Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb ### 2121875###Speaker###Senior Vice President Clinical Pharmacology, Pharmacometrics & Bioanalysis###Bristol Myers Squibb###Speaker: Akintunde Bello, PhD (he/him/his) – Bristol Myers Squibb
### he/him/his @@@ Amita Joshi, PhD (she/her/hers) – Genentech ### 2121876###Speaker###Vice President, Clinical Pharmacology###Genentech###Speaker: Amita Joshi, PhD (she/her/hers) – Genentech
### she/her/hers @@@ Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool ### 2121877###Speaker###Senior Lecturer###University of Liverpool###Speaker: Adeniyi Olagunju, PhD (he/him/his) – University of Liverpool
### he/him/hisChair: Tomoyuki Mizuno, PhD – Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center
Chair: Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna
Speaker: Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges
Speaker: Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX
Speaker: Ethan Poweleit – Cincinnati Children's Hospital Medical Center
Precision Dosing (PD)
Pharmacometrics & Pharmacokinetics (PMK)
Chair: Tomoyuki Mizuno, PhD – Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center
### @@@ Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna ### 2121881###Chair###Assistant Professor of Clinical Pharmacometrics, Pharmacist###Medical University of Vienna###Chair: Iris K. Minichmayr, PhD (she/her/hers) – Medical University of Vienna
### she/her/hers @@@ Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges ### 2121882###Speaker###Professeur des Universités Praticien Hospitalier (PUPH)###Limoges University Hospital, Inserm U1248, University of Limoges###Speaker: Jean-Baptiste Woillard, PharmD, PhD (he/him/his) – Limoges University Hospital, Inserm U1248, University of Limoges
### he/him/his @@@ Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX ### 2121883###Speaker###Director of Data Science###InsightRX###Speaker: Jasmine Hannah Hughes, PhD (she/her/hers) – InsightRX
### she/her/hers @@@ Ethan Poweleit – Cincinnati Children's Hospital Medical Center ### 1144043###Speaker###PhD Candidate###Cincinnati Children's Hospital Medical Center###Speaker: Ethan Poweleit – Cincinnati Children's Hospital Medical Center
###Chair: Robert E. Stratford, Jr., PhD (he/him/his) – Otsuka-US
Chair: Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics
Speaker: John McCorvy, PhD – Medical College of Wisconsin
Speaker: Matthew W. Johnson, PhD – Johns Hopkins University
Mental Health & Addiction (MHA)
Chair: Robert E. Stratford, Jr., PhD (he/him/his) – Otsuka-US
### he/him/his @@@ Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics ### 1770967###Chair###Senior Director###Cerevel Therapeutics###Chair: Gina Pastino, PhD (she/her/hers) – Cerevel Therapeutics
### she/her/hers @@@ John McCorvy, PhD – Medical College of Wisconsin ### 2121866###Speaker###Assistant Professor###Medical College of Wisconsin###Speaker: John McCorvy, PhD – Medical College of Wisconsin
### @@@ Matthew W. Johnson, PhD – Johns Hopkins University ### 2121867###Speaker###Professor###Johns Hopkins University###Speaker: Matthew W. Johnson, PhD – Johns Hopkins University
###Chair: Virginia (Ginny) D. Schmith, PhD – Schmith PK/PD Consulting LLC
Chair: Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco
Chair: Virginia (Ginny) D. Schmith, PhD – Schmith PK/PD Consulting LLC
### @@@ Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco ### 862400###Chair###Associate Professor###University of California, San Francisco###Chair: Akinyemi O. Oni-Orisan, PharmD, PhD (he/him/his) – University of California, San Francisco
### he/him/hisChair: Navin Goyal, PhD – Johnson and Johnson
Speaker: Rajendra P. Singh, PhD – Teva Pharmaceuticals
Speaker: Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration
Early Career (EC)
Regulatory Science (RS)
Chair: Navin Goyal, PhD – Johnson and Johnson
### @@@ Rajendra P. Singh, PhD – Teva Pharmaceuticals ### 2147033###Speaker###Senior Director###Teva Pharmaceuticals###Speaker: Rajendra P. Singh, PhD – Teva Pharmaceuticals
### @@@ Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration ### 1143796###Speaker###Pharmacologist###U.S. Food and Drug Administration###Speaker: Yuqing Gong, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hersChair: Zhu Zhou, PhD (she/her/hers) – City University of New York
Chair: Liang Zhao, PhD, MBA – US Food and Drug Administration
Speaker: Anshul Kanakia, PhD (he/him/his) – AstraZeneca
Speaker: Mark Sale, MD (he/him/his) – Certara
Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
Regulatory Science (RS)
Pharmacometrics & Pharmacokinetics (PMK)
Chair: Zhu Zhou, PhD (she/her/hers) – City University of New York
### she/her/hers @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Chair###Division Director###US Food and Drug Administration###Chair: Liang Zhao, PhD, MBA – US Food and Drug Administration
### @@@ Anshul Kanakia, PhD (he/him/his) – AstraZeneca ### 2188216###Speaker###Director, Data Science###AstraZeneca###Speaker: Anshul Kanakia, PhD (he/him/his) – AstraZeneca
### he/him/his @@@ Mark Sale, MD (he/him/his) – Certara ### 2121851###Speaker###Vice President###Certara###Speaker: Mark Sale, MD (he/him/his) – Certara
### he/him/his @@@ Liang Zhao, PhD, MBA – US Food and Drug Administration ### 1143392###Speaker###Division Director###US Food and Drug Administration###Speaker: Liang Zhao, PhD, MBA – US Food and Drug Administration
###